Literature DB >> 194813

Hepatic tumors: possible relationship to use of oral contraceptives.

G Klatskin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194813

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  53 in total

Review 1.  Focal nodular hyperplasia--a review of myths and truths.

Authors:  Christopher B Nahm; Kevin Ng; Philip Lockie; Jaswinder S Samra; Thomas J Hugh
Journal:  J Gastrointest Surg       Date:  2011-09-30       Impact factor: 3.452

Review 2.  The changing face of hepatic resection.

Authors:  S Iwatsuki; D G Sheahan; T E Starzl
Journal:  Curr Probl Surg       Date:  1989-05       Impact factor: 1.909

3.  Recurrent hepatic hemangiomas. Possible association with estrogen therapy.

Authors:  R L Conter; W P Longmire
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

4.  Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental discovery after long-term oral contraceptive use.

Authors:  J Korula; A Yellin; G Kanel; G Campofiori; P Nichols
Journal:  West J Med       Date:  1991-10

Review 5.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

6.  Oral contraceptives and six benign liver tumors-the mestranol question.

Authors:  A D Barnes; R P Hattis; P J Toot
Journal:  West J Med       Date:  1984-06

7.  Pill-induced liver disease.

Authors:  P Devenyi
Journal:  Can Fam Physician       Date:  1978-10       Impact factor: 3.275

Review 8.  Adverse reactions and drug interactions with radiopharmaceuticals.

Authors:  C B Sampson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 9.  Drug-induced liver disease.

Authors:  H J Zimmerman
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.